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A B S T R A C T
Objective: At the present, it is unclear whether association of basal forebrain
cholinergic system (BFCS) volume with cognitive performance exists in healthy as well as in cognitively impaired elderly subjects. Whereas one small study reported
an association of BFCS volume with general cognitive ability ‘g’ in healthy ageing, effects on specific cognitive domains have only been found in subjects with
cognitive decline. Here we aim to clarify whether an association of BFCS volume and ‘g’ is present in a larger sample of elderly subjects without obvious symptoms of
dementia and whether similar associations can also be observed in specific cognitive domains.
Methods: 282 pre-surgical patients from the BioCog study (aged 72.7 ± 4.9 years with a range of 65–87 years, 110 women) with a median MMSE score of 29 points
(range 24–30) were investigated. BFCS and brain volume as well as brain parenchymal fraction were assessed in T1-weighted MR images using SPM12 and a
probabilistic map of the BFCS. Neuropsychological assessment comprised the CANTAB cognitive battery and paper-and-pencil based tests. For data analysis, gen-
eralised linear models and quantile regression were applied.
Results: Significant associations of BFCS volume with ‘g’ and several cognitive domains were found, with the strongest association found for ‘g’. BFCS volume
explained less variance in cognitive performance than brain volume. The association was not confounded by brain parenchymal fraction. Furthermore, the asso-
ciation of BFCS volume and ‘g’ was similar in high- and low-performers.
Conclusion: Our results extend previous study findings on BFCS volume associations with cognition in elderly subjects. Despite the observed associations of BFCS
volume and cognitive performance, this association seems to reflect a more general association of brain volume and cognition. Accordingly, a specific association of
BFCS volume and cognition in non-demented elderly subjects is questionable.
1. Introduction
The basal forebrain is the main source of acetylcholine (ACh) for
hippocampal and neocortical structures. The basal forebrain cholinergic
system (BFCS) comprises the medial septum nuclei (Ch1), Broca's di-
agonal (Ch2) and horizontal nuclei (Ch3) as well as the Nucleus basalis
of Meynert (Ch4) and the Nucleus subputaminalis of Ayala (Mesulam
et al., 1983; Simić et al., 1999). Its main neurotransmitter acetylcholine
is well known to play a role in cognition which has been shown in
several neurophysiological experiments and lesion studies of the BFCS
(Parikh et al., 2007; Harati et al., 2008; Cai et al., 2012).
In patients with Alzheimer's Dementia (AD), the number of choli-
nergic neurons in the human brain is diminished (White et al., 1977;
Kilimann et al., 2014). Furthermore, MRI studies have shown that
cholinergic atrophy parallels cognitive decline as the disease process is
progressing (Grothe et al., 2013). Current treatment strategies of Alz-
heimer's dementia aim at compensation for the cholinergic deficit by
administration of ACh-esterase inhibitors (Birks 2006; Winblad et al.,
2001). These drugs increase neurotransmitter persistence in the sy-
naptic cleft by pharmacological inhibition of its degradation,
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ameliorating cognitive symptoms (Anand and Singh, 2013).
Atrophy of cholinergic cells in the basal forebrain is also seen in
healthy elderly subjects without clinical evidence of dementia (Grothe
et al., 2012, 2013; Teipel et al., 2015). Post mortem studies reported a
decrease of histological markers of ACh-synthesis and cholinergic sy-
napses during normal ageing which is accelerated in AD patients
(Sparks et al., 1992; Perry et al., 1992). However, it is still controversial
whether cholinergic deficits are also associated with age-associated
cognitive decline in subjects without evidence of dementia develop-
ment. Wolf et al. (2014) recently reported an association of BFCS vo-
lume with cognitive performance in a small group of healthy elderly
subjects without evidence of dementia. On the other hand, ACh-es-
terase-inhibitors have not been proven effective in elderly patients with
memory complaints without dementia (mild cognitive impairment) and
cholinergic cell loss seems to occur at advanced stages of AD (Russ and
Morling, 2012; Gilmor et al., 1999). Furthermore, histological studies
suggested that 30% of cholinergic neurons in the basal forebrain need
to be lost until relevant cognitive deficits manifest (Mini-Mental State
Examination/MMSE<24) which is questioning an association of cog-
nition and basal forebrain volume in healthy ageing (Schliebs and
Arendt, 2006).
Associations of BFCS subregion volumes and cognitive domains
(episodic memory, executive functions) were reported for patients with
mild cognitive impairment (MCI). This association was not observed in
the healthy control group (Grothe et al., 2010, 2016). Since these stu-
dies were designed to investigate differences between healthy elderly
and patients with mild cognitive impairment, one needs to take into
account that the control group was strictly defined as a highly func-
tional (“hypernormal”) control group without the slightest suspicion for
cognitive impairment. Thus, Grothe et al. (2016) used a control group
from the Alzheimer's Disease Neuroimaging Initiative (ADNI-2) com-
prising individuals without any memory complaints, normal memory
function according to the Wechsler Memory Scale-R and a Clinical
Dementia Rating Scale (CDR) score of 0. In addition, subjects with
significant systemic illness or unstable medical condition were not in-
cluded in the control group. Since multimorbidity has been shown to be
associated with age and cognitive impairment, exclusion of participants
due to non-neurocognitive medical conditions affects the prevalence of
age-associated cognitive decline in the sample (Barnett et al., 2012;
Vassilaki et al., 2015).
The aim of the present study is the analysis of BFCS volume asso-
ciations with cognitive performance in a natural rather than a “hy-
pernormal” cohort of elderly pre-surgical patients (≥ 65 years) without
obvious symptoms of clinical dementia (MMSE score median 29 points,
range 24–30, Folstein et al., 1975).
2. Methods
2.1. Participants
Participants were recruited as part of the BioCog project (Biomarker
Development for Postoperative Cognitive Impairment in the Elderly
study, www.biocog.eu), which is a prospective multicentre cohort study
with the aim to develop a biomarker-based algorithm for risk prediction
of post-operative cognitive disorders. Only patients ≥ 65 years of age
presenting for an elective major surgery were recruited (for further
inclusion and exclusion criteria see Table 1).
All patients gave written informed consent to participate in the
study. The study protocol was approved by the local ethics committees
and conducted in accordance with the declaration of Helsinki. The
study was registered at clinicaltrials.gov (NCT02832193).
In line with the study protocol, the first 400 out of 1033 participants
recruited at two study centres in Berlin, Germany (N=291) and
Utrecht, Netherlands (N=109) were selected for this interim analysis.
In total, 2733 patients were screened for inclusion in the interim sample
in both study centres. 297 out of 400 patients underwent anatomical
neuroimaging. Two patients were excluded due to brain pathology in-
terfering with the segmentation procedure. Thirteen datasets were in-
complete with regard to demographic data or patients did not perform
cognitive testing at all. Finally, data from 282 participants are included
in the analysis (N= 204 from Berlin, N= 78 from Utrecht).
Neuropsychological data were incomplete for several participants re-
ducing the final sample size for test analysis.
2.2. Neuropsychological assessments
One day before surgery, all participants underwent a comprehensive
computerised neuropsychological test battery (CANTAB, Cambridge
Cognition Ltd., UK), comprising the Paired Associate Learning (PAL),
Verbal Recognition Memory (VRM), Spatial Span Length (SSP) and
Simple Reaction Time (SRT). Additionally, pen-and-paper versions of
the Trail-Making-Test (TMT, Parts A and B) and a manual dexterity test
called the Grooved Pegboard Task (GPT) were conducted. Testing was
performed by trained doctoral students and study nurses based on a
standard operating procedure which was consented with two neu-
ropsychologists.
PAL: The participant is shown different patterns in fixed locations
on a screen in a randomised order. Subsequently, the patterns are ob-
scured and the participant is asked to indicate the location where a
particular pattern has been shown previously. In case of an error, the
participant is asked to repeat the task for a maximum of ten trials. The
task is then repeated on another stage with increased difficulty level.
The first trial memory score is calculated as the number of patterns
correctly allocated at first attempt for all completed stages. The PAL
memory score assesses explicit visuospatial memory and has been found
to indicate dementia, especially of Alzheimer's type (Lee et al., 2003).
VRM: The participant is shown a list of twelve words and asked to
recall freely as many items as possible. Subsequently, the participant is
shown a second list including the previously presented words as well as
distractors and is asked to choose the items he or she recognises. The
recognition procedure is repeated after twenty minutes. The number of
items recognised after delay is analysed, since recognition memory has
been shown to be associated with medial septal volume in the BFCS in
younger participants (Butler et al., 2012). Furthermore, two studies
suggest associations of BFCS volume with delayed recall in memory
tasks (Grothe et al., 2010, 2016).
SSP: The participant is shown colour changing boxes on a screen. He
or she is then asked to indicate the correct sequence by which the boxes
have changed colours. The parameter of interest analysed is the longest
sequence of boxes recalled (span length), which is thought to represent
visual working memory (Monaco et al., 2013).
SRT: The participant is shown a square on a computer screen. He or
she is asked to respond to this stimulus by selecting a button as fast as
possible. Mean response latency (reaction time) is the parameter of
interest. Reaction time is considered to be a marker of fluid intelligence
and age-associated decline in cognitive ability (Der and Deary, 2018).
TMT: The participant is asked to connect dots marked with as-
cending numbers in Part A or alternating numbers and letters (e.g. 1-A-
2-B-3…) in Part B. When a mistake is made, the participant is asked to
correct it. Time for completion of both parts is the parameter of interest.
Values above commonly used cut-off thresholds (180s for TMT-A, 300s
for TMT-B) were excluded during a plausibility check before data
analysis. Part A is considered to be a measure of visual search and
motor speed, whereas part B measures executive functions including
cognitive alternation, working memory and attention (Bowie and
Harvey, 2006; Crowe, 1998).
GPT: The participant is asked to insert 25 pegs with a key alongside
into wholes in a board. The key slots are rotated randomly, demanding
visual-motor coordination skills and manual dexterity (Otten et al.,
2012). Test parameter of interest is the time for completion with the
dominant hand. Data from participants who exceeded a limit of 300 s
for this task were excluded during the plausibility check.
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Global cognitive ability ‘g’: The global cognitive component is de-
rived from performance on the neurocognitive battery (above) using
Principal Component Analysis (PCA) in line with previous literature
(Staff et al., 2006, Shenkin et al., 2009). The first unrotated factor was
extracted from data of 303 participants enrolled at both study centres in
Berlin and Utrecht with complete neurocognitive assessment. The first
factor had an eigenvalue of 2.3 and explained 38.33% of the variance in
test performance and is considered the global cognitive ability. In our
study the factor is derived from TMT-B (factor loading 0.76), PAL
(factor loading: 0.71), GPT (factor loading: 0.68), SSP (factor loading:
0.55), SRT (factor loading: 0.49) and VRM (factor loading: 0.46). Due
skewed distributions, time for completion of TMT-B and GPT as well as
SRT mean latency were reversed and underwent logarithmic transfor-
mation prior to PCA. The test outcomes used for extraction of 'g' are
those stated above except for the VRM: The number of words correctly
remembered in the free recall has been used for calculation of g, but
based on existing literature, the delayed recognition task seemed more
relevant for analysis of BFCS volume associations with VRM perfor-
mance (Butler et al., 2012; Grothe et al., 2010, 2016).
2.3. MR image acquisition
MR imaging was conducted on the same day the neurocognitive
assessments took place. In Berlin, data were collected at the Berlin
Center for Advanced Neuroimaging using a 3 T Magnetom Trio MR
scanner (Siemens) with a 32-channel head coil. T1-weighted 3D
structural brain scans were acquired using a MPRAGE sequence (mag-
netisation prepared rapid gradient echo in 192 sagittal slices, FOV:
256·256 mm2, voxel size: 1·1 mm2 at 1mm slice thickness, TR: 2500ms,
TE: 4.77ms, 7° flip angle). In Utrecht, data were collected with an
Achieva 3 T MRI scanner (Phillips) equipped with an 8-channel head
coil. For technical reasons, the scanner at this study site had to be ex-
changed with an identical machine equipped with a 32-channel head
coil during the study. A similar T1w sequence was recorded here (192
sagittal slices, FOV: 256·232mm2, voxel size 1·1 mm³ at 1mm slice
thickness, TR: 7.9 ms, TE: 4.5ms, 8° flip angle).
A board-certified neuroradiologist screened all MR images for in-
cidental findings with clinical relevance.
2.4. MRI processing
2.4.1. Segmentation of brain volume and brain parenchyma fraction
T1-weighted MR images were partitioned into grey and white
matter as well as cerebrospinal fluid using the standard SPM12 seg-
mentation routine (http://www.fil.ion.ucl.ac.uk/spm/software/
spm12/) in a MATLAB environment (The Mathworks, Inc., Natick,
MA). Partition volume was defined as the sum of all voxels with at least
50% probability to correspond to the respective partition. Total brain
volume is calculated as the sum of grey and white matter. Intracranial
volume (ICV) is defined as the sum of brain volume and cerebrospinal
fluid volume. Brain parenchyma fraction (BPF) is defined as the ratio of
brain volume and intracranial volume which is a global marker for age
related neurodegeneration. BPF decreases during ageing and has been
associated with disease related cognitive impairment in Multiple
Sclerosis (Blatter et al., 1995; Hohol et al., 1997; Matsumae et al., 1996;
Smith et al., 2008). ICV is thought to be driven by brain growth during
childhood and does not undergo shrinkage in ageing (Davis and Wright,
1977; Pfefferbaum et al., 1994). We thus consider ICV a biomarker for
archaeological maximum brain size and the BPF a marker of preserved
brain volume and the degree of age related atrophy (Shenkin et al.,
2009).
2.4.2. Segmentation of the BFCS
We have previously described the segmentation method we used for
the volumetry of the BFCS (Lammers et al., 2016). Butler et al. (2014)
described a similar method and they were able to show that the results
are comparable to manual segmentation techniques.
Segmentation of the BFCS was performed using a probabilistic map
of the basal forebrain presented by Zaborszky et al. (2008) which has
been used in several previous imaging studies (Grothe et al., 2010;
Butler et al., 2012, 2013, 2014; Li et al., 2014a; Kline et al., 2016;
Cantero et al., 2017). Zaborszky and colleagues used histological slices
and corresponding MR images of ten post-mortem body-donor brains
(five female, age 37–75 years) without known neurological or psy-
chiatric disease to define four cholinergic subregions in the basal
forebrain. Brain sections were stained for cell bodies using a modified
silver method of Gallyas. A comprehensive description of the BFCS
delineation is found in the original publication (Zaborszky et al., 2008).
The probabilistic map uses a modified version of the Mesulam no-
menclature. Furthermore, apart from dense cell aggregates, also scat-
tered magnocellular neurons in adjacent structures (e.g. the basal
ganglia) were included. Studies identified these neurons as cholinergic,
suggesting that these are displaced cells of the Nucleus basalis Meynert
(Saper and Chelimsky, 1984; Mesulam and Geula, 1988). It is a point of
discussion whether researchers should refer to these scattered neurons
as a part of the Ch1-Ch4 system (Mesulam and Geula, 1988; Halliday
et al., 1993).
A voxel in this map was assigned to one of the subregions which it
represented in at least four out of ten brains. The final map was refer-
enced to the anatomical MNI (Montreal Neurological Institute) space
(Holmes et al., 1998).
SPM12 was used to segment MR images as well as the anatomical
MNI reference brain. The DARTEL (Diffeomorphic Anatomical
Registration using Exponentiated Lie algebra) toolbox was then used to
create DARTEL flow fields describing deformations from the MNI re-
ference brain to a participant's individual brain (Ashburner, 2007).
These deformations were applied to the probabilistic map of the basal
forebrain resulting in individual labelling of cholinergic subregions in a
participant's brain scan. Volumes of cholinergic subregions in the basal
forebrain were determined by counting all voxels labelled as corre-
sponding to this regions. Fig. 1 shows the segmented regions in MR
images of one subject.
Table 1
Inclusion and exclusion criteria of the BioCog study.
Inclusion criteria Exclusion criteria
• Age ≥ 65 years• European descent (Caucasian)• Major elective surgery with planned operation time ≥ 60min• Ability to give informed consent
• MMSE score ≤ 23 points at inclusion• Neuropsychiatric morbidity (including addiction), which limits the conduction of the neurocognitive
testing
• Anacusis or hypacusis, which limits the conduction of the neurocognitive testing• Centrally acting medication (e.g. antidepressants or tranquillizers)• Homelessness or inability to reach patient for follow-up• Participation in another prospective interventional clinical study during hospital stay• Accommodation in an institution due to an official or judicial order• Missing informed consent for saving and handing out pseudonymous data
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2.5. Statistical analysis
2.5.1. Analysis pipeline
We first analysed the association of BFCS volume with the global
cognitive component ‘g’ (primary parameter of interest). We report
unadjusted and adjusted associations (for age, sex and education) in
generalised linear models. To assess confounding effects of global vo-
lumes, the goodness of fit of a model including BFCS volume was
compared with models including brain volume and BPF. We further
analysed the associations of BFCS volume with ‘g’ after addition of these
confounder variables into the model. We repeated the analysis cor-
recting for scanner and centre effects. Since adjustment for these did not
change the results, nor significant effects were found, the variables
were dropped for post-hoc analysis of test performance analysis.
In addition, subsequent descriptive analyses were conducted to as-
sess associations of BFCS volume and performance on each of the in-
dividual tests of the neurocognitive battery (secondary, post-hoc para-
meters of interest). If test performance was significantly associated with
BFCS volume without adjustment, it was considered for further analysis
of adjusted effects. To further assess if associations of BFCS volume with
test performance are specific for a cognitive domain, we adjusted the
linear model for ‘g’.
In a final step, cognitive performance was analysed for quantile-
dependent effects of BFCS on ‘g’ and performance on individual cog-
nitive tests. This allows assessment of associations of BFCS volume with
cognitive functions which are specific for low- and high-performers.
All statistical analyses were run in R3.4.1 (https://www.R-project.
org/, R Core Team, 2017). The level of significance was set at
p < 0.05. No corrections for multiple comparisons were made.
2.5.2. Descriptive analysis
We report test performance including median performance, inter-
quartile range and minimum-maximum range. Demographic and neu-
ropsychological data have been compared between centres.
Neuroimaging data have also been compared between MR scanners. We
used the ANOVA F-test for continuous normal, the Kruskal-Wallis-test
for continuous non-normal distributions and the χ2-test for nominal
data. Correlations among independent variables are reported as
Pearson's correlation coefficient R.
2.5.3. Generalised linear model
We analysed the associations of BFCS volume and its subregions (in
mm3 and per one standard deviation/SD) with cognitive performance.
If a significant association of BFCS volume with subtest performance
was found, we adjusted the generalised linear model (GLM) for edu-
cation (classified according to ISCED/International standard classifi-
cation of education in three categories), age and sex. For ‘g’, TMT, SRT
latency, PAL memory score and GPT a Gaussian distribution was as-
sumed, for SSP and VRM a quasi-Poisson distribution was selected.
TMT, SRT and GPT scores were log-transformed before analysis. For
Gaussian-distributed data, R2 is reported and for quasi-Poisson dis-
tributed tests, D2 is reported (Guisan and Zimmermann, 2000): D2
= (Null deviance – Residual Deviance)/Null Deviance and partial D2
= (Residual DevianceReduced Model – Residual DevianceFull Model)/
Fig. 1. Location of the BFCS in one individual. The Ch1/2 region is displayed in blue, Ch3 in red. Ch4 is shown in yellow and Ch4p corresponds to the green area. We
refer to a modified version of the Mesulam-nomenclature (Zaborszky et al., 2008). (For interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
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Residual DevianceReduced Model.
2.5.4. Quantile regression analysis
In a second approach, cognitive performance was analysed using
quantile regression (Koenker and Hallock, 2001). The rationale for
quantile regression is robustness against heteroscedasticity and outliers
in neuropsychological data. Rather than analysing the conditional mean
as it is done with ordinary least squares (OLS) regression in GLM,
quantile regression calculates conditional quantiles. E.g. quantile re-
gression at the 0.5 quantile yields the median of a distribution of the
dependent variable for a given value of the independent variable,
whereas OLS regression returns the corresponding mean. Furthermore,
the analysis of quantiles other than the 0.5th allows assessment of ef-
fects at the upper or lower boundaries of a distribution. This approach
has appealing properties, when relevant covariates exit, but cannot be
included in the regression model (Cade and Noon, 2003). On the other
hand, quantile regression allows analysis of associations in high- and
low-performing strata of the study sample.
Regression coefficients for different quantiles can be compared and
tested for a statistically significant difference (referred to as hetero-
geneity of slopes). Heterogeneity of slopes suggests that volume affects
the shape of a distribution rather than a central shift.
No transformations were applied to these variables prior to quantile
regression analysis, but since count data are not eligible for quantile
regression, span length was jittered to approximate a continuous dis-
tribution (Machado and Silva, 2005).
The Barrodale and Roberts algorithm implemented in the quantreg
package was used for computation of quantile regression coefficients
(https://CRAN.R-project.org/package=quantreg, Koenker, 2017). We
report quantile regression results in scatter plots with quantile regres-
sion lines and quantile-coefficent plots (Q-C plots) for nine even spaced
quantiles (0.1–0.9) with 95% confidence intervals (CI). Heterogeneity
of slopes between the 0.5th and the lowest performing quantile (0.1th
or 0.9th, respectively) was analysed using ANOVA. CI and p-values are
based on the assumption of non-identical standard errors (called “nid”
in the quantreg code).
3. Results
Fig. 2 is the Consort Diagram for the sample. Demographic in-
formation on the study participants is provided in Table 2. Neu-
ropsychological test performance including the respective number of
analysed datasets is reported in Table 3. Only TMT-B performance
(median [IQR]: Berlin 101.98 s [86.25–136.5 s], Utrecht 104.1 s
[75–118.8 s], χ2 = 6.35, p=0.0118) and educational status
(ISCED1–2 and ≥5: Berlin 21.1% and 34.3%, Utrecht: 28.2% and
44.9%, χ2 = 6.64, p=0.0361) differ significantly between centres.
Significant between-centre differences are found for BFCS volume
(F1,279 = 8.65, p=0.0036, Δ=93mm3), total brain volume (F1,279
= 5.37, p= 0.0212, Δ=43 cm3) and BPF (F1,279 = 6.69, p=0.0102,
Δ=0.014, Table 4). Mean volumes are higher in the Utrecht sample.
Between-scanner effects for the study centre in Utrecht are not sig-
nificant.
BFCS volume correlates with age (R = − 0.26, p < 0.0001), total
brain volume (R=0.83, p < 0.0001) and BPF (R = 0.25,
p < 0.0001). BFCS volume (F1,280 = 75.69, p < 0.0001), total brain
volume (F1,280 = 77.06, p < 0.0001) and BPF (F1,280 =11.02,
p=0.0010) differ by sex. BFCS and brain volume are larger in men,
while BPF is higher in women. Differences by education are found for
BFCS volume (F2,279 =3.27, p= 0.0397), total brain volume (F2,279
=7.95, p= 0.0004), but not for BPF (F2,279< 0.01, p= 0.85). BFCS
and brain volumes are larger in more educated subjects.
3.1. Associations of BFCS volume with global cognitive ability
Our primary hypothesis is an association of BFCS volume with
global cognitive ability: BFCS volume is significantly associated with ‘g’
(R2 = 0.061, p= 0.0001, see Fig. 3). This association is largely in-
dependent of age, education and sex and remains significant after ad-
justment for these variables (R2 = 0.287, partial R2 = 0.041,
B=0.204 ± 0.064 per SD, p=0.0017, see Table 5).
Association of BFCS subregions (CH1/2, CH3, CH4, CH4p) with
global cognition are also assessed. After correction for age, sex and
education, all subregions are significantly associated with ‘g’, and the
association of BFCS with general cognition was slightly inferior to the
association of ‘g’ and the most posterior subregion CH4p. According to
R2, CH4p (R2 =0.290, partial R2 =0.045, p=0.0009) is slightly more
relevant for ‘g’ than more rostral regions CH1/2 (R2 =0.281, partial R2
=0.032, p=0.0057), CH3 (R2 =0.271, partial R2 =0.019,
p=0.0352) and CH4 (R2 =0.276, partial R2 =0.026, p=0.0127).
Associations of confounding global anatomical volumes (brain
Fig. 2. Consort diagram. For this cross-sectional analysis, datasets have been
included which have been defined as drop-outs for longitudinal analysis due to
missing primary endpoints (assessment of post-operative delirium). AE refers to
adverse event.
Table 2
Demographic description of the study sample. ISCED refers to the International
standard classification of education.
Median Interquartile Range Range
Age (years) 72 68–76 65–87
MMSE (points) 29 28–30 24–30
N %
Sex Female 110 39%
Education ISCED 1 and 2 65 23%
ISCED 3 and 4 110 39%
ISCED 5 and higher 107 38%
F. Lammers et al. Neuropsychologia 119 (2018) 145–156
149
volume, BPF) and global cognitive abilities are tested in general linear
models adjusting for age, sex and education. A considerable improve-
ment is achieved by using a model which includes total brain volume
(R2 =0.311, partial R2 =0.073, B=0.280 ± 0.065 per SD,
p < 0.0001). The association of global cognitive ability and BPF is
significant, but was inferior to the model including brain volume (R2
=0.300, partial R2 =0.058, B=0.235 ± 0.062 per SD, p=0.0002).
BFCS volume and each one of the potentially confounding volume
measures are then added concurrently into two further general linear
models of ‘g’. When total brain volume and BFCS are included in the
same model alongside with age, sex and educational status, only the
association of total brain volume with global cognitive ability remains
significant (partial R2 =0.033, B=0.274 ± 0.096 per SD,
p=0.0047), but not for BFCS (partial R2< 0.001, B=0.008 ± 0.093
per SD, p= 0.93). A model including BFCS volume and BPF shows that
BFCS and BPF are independently associated with global cognitive
ability (partial R2BFCS=0.023, BBFCS=0.154 ± 0.065 per SD,
pBFCS=0.0191; partial R2BPF=0.040, BBPF=0.198 ± 0.063 per SD,
pBPF=0.0019).
There is no significant effect of MR scanner or study centre, nor does
adjustment for these alter the results.
3.2. Associations of BFCS volume with test performance
In the unadjusted analyses, BFCS volume is significantly and posi-
tively associated with performance in all tests, except delayed re-
cognition in the VRM.
The strongest associations are seen for TMT-B and SRT latency (R2
=0.073 and 0.048, respectively). Somewhat weaker associations are
also found for PAL memory score, TMT-A, GPT (see Fig. 4) and the SSP
(D2 =0.030, B=0.00015 ± 0.00005, BSD=0.034 ± 0.012,
p=0.0034, not presented in Fig. 4). Using a Bonferroni-corrected level
of significance p′ to account for testing associations with seven cogni-
tive tests (p′=0.05/7 ≈0.0071), only the unadjusted associations of
BFCS volume with TMT-A and -B, SRT as well as SSP remained sig-
nificant. Adjusting for age, education and sex yields similar associations
of BFCS volume with PAL memory score, SRT latency, TMT-B and GPT.
R2 for these models was lower than for the model of ‘g’. Associations
with TMT-A performance and span length are no longer significant after
adjustment for age, sex and education (see Table 6).
VRM is the only test without significant association with BFCS vo-
lume (D2 =0.005, BSD=0.011 ± 0.009, p= 0.22). The result for the
VRM does not change after rejection of two outlying subjects (D2
=0.003, BSD=0.0060 ± 0.0068, p= 0.38).
After adjustment for global cognitive abilities, only TMT-B perfor-
mance was significantly associated with BFCS volume (partial R2
= 0.018, p=0.0378). This association was no longer significant after
further adjustment for age, sex and education (partial R2 = 0.007,
p=0.19).
3.3. Quantile regression analysis
Fig. 5A and B are a graphical summary of quantile regression results
of global cognitive ability and test performance. ANOVA for hetero-
geneity of slopes indicates that differences between associations of
BFCS volume and cognitive performance between 0.5th and 0.9th
quantile exist for SRT latency and GPT, but neither for the other tests
Table 3
Summary of cognitive performance: Number of available datasets (N), median, full and interquartile range of performance.
Test Parameter of interest N Median Interquartile Range Range
SRT Mean correct latency (ms) 282 290.2 252.1–348.6 200.8–801.4
TMT-A Time for completion (s) 267 45 36.02–57.50 19–132
TMT-B Time for completion (s) 250 100 81–113.04 25.39–298
GPT Time for completion (s) 270 93 80–110 50–254.27
SSP Span length 280 5 4–5 3–8
PAL Memory score 280 13 11–17 0–25
VRM Number of correctly recognised items after delay 221 22 20–23 0–24
Global cognition ‘g’ 243 0.10 -0.50–0.74 -2.70–2.35
Table 4
Summary of volumetric data: Median, full and interquartile range.
Median Interquartile Range Range
BFCS volume (mm³) 2201 2035–2350 1600–2875
Brain volume (cm³) 999.9 921.7–1077.4 720.6–1280.7
BPF (fraction) 0.68 0.65–0.71 0.47–0.81
Fig. 3. Association of BFCS volume with global cognitive ability. B indicates the
change in 'g' per 1mm3 and one standard deviation (B-SD) change in BFCS
volume. Regression coefficients (B), p-value and R2 correspond to the un-
adjusted model.
Table 5
General linear model (GLM) describing BFCS volume associations with global
cognitive abilities. Regression coefficients are indicated as B with standard
error (SE) and the corresponding p-value. SD refers to standard deviation.
Independent variable B±SE p
BFCS volume in mm³ (change
per SD)
0.00090 ± 0.00028
(0.204 ± 0.064)
0.0017
Age in years − 0.059 ± 0.011 < 0.0001
Male sex − 0.347 ± 0.129 0.0075
ISCED level 1+ 2 − 0.449 ± 0.138 0.0013
ISCED level 5 and higher 0.497 ± 0.122 < 0.0001
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nor ‘g’.
For the global component, results from the GLM are reproduced in
quantile regression. The association of BFCS volume and 'g' showed no
quantile-dependent trend, with significance found for all quantiles in
the unadjusted model. After adjustment, significance was restricted to
quantiles close to the median (B=0.0010 ± 0.0003,
BSD=0.220 ± 0.076, p= 0.0043).
For TMT-A and -B, PAL and SSP median regression coefficients were
acceptably close to the OLS estimate. Neither ANOVA nor inspection of
plots suggested systematic quantile-dependent associations, especially
not after adjustment for age, sex and education. With regard to sig-
nificance, differences between the analysis methods occurred. On the
one hand, parametric methods can be more efficient than alternative
methods when data are normally distributed, explaining the more op-
timistic results of the GLM for the association with PAL (Kitchen, 2009).
On the other hand, GLM standard errors are sensitive to outliers and
skewed distributions, yielding more favourable results of quantile re-
gression (Wilcox, 2012).
Results for the SRT and GPT differ from GLM results. For these tests,
BFCS volume association with test performance differs significantly
between the 0.5th and 0.9th quantile with a stronger association for the
low-performance quantiles (0.9th, see Fig. 5B). In the adjusted models
regression coefficients for the 0.1th to the 0.7th quantile are close to
zero, but significant effects are found at higher quantiles for SRT la-
tency (0.9th quantile: B=-0.198 ± 0.042, B=-44.6 ± 9.5 per SD,
p < 0.0001) and GPT completion time (0.9th quantile: B=-
0.053 ± 0.018, B=-12.0 ± 4.0 per SD, p=0.0031).
4. Discussion
In the current study, we analysed the associations of BFCS volume
with global cognitive ability and performance on several age-sensitive
cognitive tests in a sample of elderly pre-surgical patients. We found
significant positive associations of BFCS volume with global cognition
and tests of visual memory, manual dexterity, processing speed and
executive functions. BFCS volume explains more variance in the global
component than in any of the cognitive test outcomes. E.g., in-
dependent of age, sex and educational status, BFCS volume explains
4.1% of the variance in ‘g’, but only 3.6% or less variance in test per-
formance. This result suggests that BFCS volume is associated with
better overall cognitive function in ageing rather than affecting a spe-
cific cognitive domain. This conclusion is further supported by our
finding that performance in cognitive tests was no longer independently
associated with BFCS volume when analyses were adjusted for ‘g’,
suggesting that global cognitive abilities mediate the associations with
test performance. However, the association of BFCS volume with global
Fig. 4. Association of BFCS volume with test performance. B indicates the
change in the test parameter per 1 mm3 and one standard deviation (B-SD)
change in BFCS volume. Regression coefficients (B), p-value and R2 correspond
to the unadjusted model.
Table 6
Adjusted GLM for associations of BFCS volume with test parameters. All GLM
are adjusted for age, sex and education. Associations are listed as regression
coefficients (B) with standard errors per one SD (standard deviation) change of
BFCS volume. P-values, R2 and partial R2 for BFCS volume are indicated, except
for the SSP: These values marked with an asterisk (*) correspond to D2. p-values
have not been corrected for multiple tests. p-values marked with a double as-
terisk (**) are significant after Bonferroni correction for independent tests
(p′<0.0071).
Test B± SE for BFCS volume per
SD
(p) Partial R2
(D2)
R2 (D2)
PAL 0.632 ± 0.294 (0.0325) 0.017 0.146
TMT-A
(log)
− 0.030 ± 0.024 (0.22) 0.006 0.129
TMT-B
(log)
− 0.084 ± 0.028 (0.0030**) 0.036 0.241
SRT (log) − 0.039 ± 0.017 (0.0245) 0.018 0.075
GPT (log) − 0.046 ± 0.017 (0.0085) 0.026 0.192
SSP 0.016 ± 0.013 (0.22) 0.005* 0.115*
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cognitive ability is driven by a more general association of total brain
volume and cognition. BPF and BFCS volume are independently asso-
ciated with cognition, suggesting BFCS volume has a beneficial function
for cognitive reserve in atrophy-related cognitive decline. We further
found that whereas the association of BFCS volume and global cogni-
tion is stable for all levels of performance, the association with SRT and
GPT performance is only found for low-performing participants.
Our study needs to be discussed in the context of results reported by
Wolf et al. (2014) and Grothe et al. (2016). The former work analysed
associations of BFCS subregion volumes with global cognition and test
performance in 43 healthy adults aged 60–85 years with a very high IQ.
After correction for intracranial volume, age and education they re-
ported a significant association with global cognitive ability, but not
with performance in single cognitive domains. Wolf's results support
our findings with regard to an association of BFCS volume with global
cognition rather than single test performance. Furthermore, we found a
Fig. 5. A: Quantile regression results of ‘g‘ and test performance. The left column shows scatter plots with regression lines for the 0.1th, 0.5th (median) and 0.9th
quantile. The columns on the right display quantile-coefficient plots for simple (unadjusted, middle) and multiple quantile regression adjusting for age, sex and
education (right). The regression coefficient for BFCS volume (white –■–) are displayed for each quantile (x-axis) with 95% CI (blue area). Solid and dashed lines
mark the OLS regressions result with 95% CI. ANOVA results correspond to analysis for slope heterogeneity between median and lowest-performing quantile. (For
interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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similar pattern of BFCS subregion contribution to global cognition:
Total BFCS volume and posterior compartments (Ch4p) seem to be
more relevant than anterior sections. In our study, the association of
BFCS volume with ‘g’ was stronger than with performance in any cog-
nitive test. Thus it is likely that this study missed associations with test
performance due to lower statistical power.
Grothe et al. (2016) analysed the association of BFCS volume and
test performance in 132 MCI subjects and 177 “hypernormal” healthy
controls enrolled in the ADNI project. After controlling for age, sex and
education, no significant associations with subtest performance were
found in the healthy control group. Instead, significant associations
with memory and attentional control were only found in the MCI group.
Although the authors did not report analyses of global cognitive ability,
our positive findings on BFCS volume associations with performance in
single tests from the neurocognitive battery disagree with the results by
Grothe and colleagues. We think that to some extent these differences
can be explained by clinical differences in the analysed groups.
Whereas the respective studies analysed unusually high performing
elderly individuals, cognitive performance in our cohort had greater
variance and most likely includes subjects with preclinical cognitive
impairment. For instance, comparison of TMT performance, which is
reported in all aforementioned studies, suggests that Wolf et al. (TMT
mean time: A 36.6 s, B 91.1 s) and Grothe et al. (TMT mean time: A
33.7 s, B 80.3 s) analysed subject groups with better performance
compared to the BioCog cohort (TMT mean time: A 48.8 s, B 113.0 s).
Tombaugh (2004) presented age-stratified normative data for the TMT.
The average performance in Wolf's and Grothe's samples were better
than 50% and 70% of the reference group (70–74 years) in Tombaugh's
data, whereas the BioCog cohort mean corresponds to the 30th per-
centile of this reference group. We further compared TMT performance
in our sample to reference data stratified by prevalence and future in-
cidence of dementia in a sample of patients aged over 70 years (Holtzer
et al., 2008). Although TMT performance of 75% of the BioCog cohort is
close to the reference value of the group without prevalent dementia or
future conversion (TMT mean time: A 56.7 s, B128.8 s), the TMT
completion time in the worst performing quartile of our sample is closer
to the groups with incident (TMT mean time: A 87 s, B 186 s), or pre-
valent dementia (TMT mean time: A 112 s, B 208 s) in that study.
Both the sample analysed by Wolf as well as the control subjects
from the ADNI project included in the study by Grothe underwent ad-
ditional dementia screening (Clinical Dementia Rating Scale, Stamm
Screening Questionnaire and International Checklist of ICD-10 and
DSM-IV). Dementia screening in the BioCog study is restricted to con-
sultation of medical records and patient interview for neuropsychiatric
diseases as well as MMSE assessment. The MMSE score was designed
originally as a bedside screening tool for dementia, but is not generally
recommended as a diagnostic criterion for dementia (Folstein et al.,
1975; Tombaugh and McIntyre, 1992). Comparisons of the MMSE score
with the Clinical Dementia Rating Scale (CDR) in a memory clinic
suggested that among patients with score of 26–29 points, about 40%
Fig. 5. (continued)
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have a CDR score of 0.5 or 1, corresponding to probable or mild de-
mentia (Perneczky et al., 2006). The authors further reported CDR
scores of at least 0.5 (probable dementia) for all patients with MMSE
scores below 26. This study reports the limited ability of the MMSE
score to exclude patients with pre-existing cognitive impairment, which
might also apply to the BioCog study (MMSE cut-off at 24 points).
Furthermore, the BioCog study only includes elderly pre-operative pa-
tients with an indication for surgery and the overall morbidity of the
cohort is probably higher compared to the groups analysed by Grothe
et al. (2016) and Wolf et al. (2014). Vassilaki et al. (2015) reported
associations of multimorbidity and mild cognitive impairment which
implies that pre-clinical cognitive decline might occur more often in the
clinical sample presented here. Overall, our considerations suggest that
a larger proportion of patients with (mild) cognitive impairments in the
BioCog group contributes to the significant associations of cognitive
performance with BFCS volume compared to the group analysed by
Grothe et al. (2016).
To further test this assumption in our data, we used quantile re-
gression analysis to assess the association of BFCS volume with test
parameters for different levels of performance. Although in this analysis
statistical significance was found only for subjects with median global
cognitive ability, we found no quantile-dependent association of BFCS
and global cognition, suggesting that BFCS volume is associated with
better cognitive performance at all stages of age-associated cognitive
decline. Since the association seems to be very stable also for high-
performing subjects we suggest that this might contribute to the find-
ings by Wolf et al. (2014). Further analysis of SRT and GPT, which are
tests of reaction time and visual-motor control, revealed significantly
different associations for the 0.5th and the lowest performing quantile.
Independent associations have only been found in poorly achieving
subjects. These findings suggest that their association with BFCS vo-
lume seems to be specific for individuals with low task performance. It
is possible that BFCS volume limits minimum performance in these
participants, rather than improving performance in average- to high-
performers. This might point to a function of BFCS volume as a struc-
tural cognitive reserve which is recruited in low performing subjects,
but with regard to the different results of the studies mentioned above,
it shows that the association of BFCS volume with test performance
indeed depends on the overall performance level of the study group.
Whereas Wolf and Grothe might have missed significant associations by
recruiting only high performing participants, our results might be
driven by a higher fraction of subjects with relevant age-related cog-
nitive decline.
As pointed out above, most differences between studies may arise
from differences in sample composition. Even so, some additional dif-
ferences between these studies need to be taken into account. The BFCS
volumes we report are considerably larger than those reported by Wolf
and Grothe. Furthermore, the MRI derived volumes in our study are
larger than the work by Zaborszky et al. (2008) suggest. Thus, it seems
unlikely that these differences are caused by varying degrees of BFCS
atrophy between the studies. Instead, we need to take into account that
we used a probabilistic map of the BFCS which was derived from his-
tological sections of ten brains. The map summarises brain regions with
at least 40% overlap from these brains. In contrast to this, Wolf and
Grothe report to have used a BFCS map based on one single brain
(Kilimann et al., 2014). Thus, our method overestimates absolute BFCS
volume. On the other hand, the location of cholinergic cells in the basal
forebrain has high inter-individual variability, limiting the gen-
eralisability of single-subject based maps for larger populations
(Zaborszky et al., 2008). The choice of the appropriate method is thus a
point of discussion and the lack of a final recommendation reinforces
the need for different studies using complementing approaches.
Our study has greater statistical power by including more partici-
pants than Wolf and colleagues and by refusing to correct for multiple
independent tests. Especially after a significant association between ‘g’
and BFCS volume has been shown, it is not reasonable to assume
independence of the various tests ultimately constituting the basis of
global cognitive ability (Johnson et al., 2004, 2008; Deary et al., 2010).
Notably, we found no association of BFCS volume and episodic
memory in VRM. Thus our results could not reproduce findings from
studies on younger samples and MCI patients (Butler et al., 2012;
Grothe et al., 2010, 2016). Apart from differences in sample composi-
tion, methodological differences also need to be taken into account to
explain these findings. First, only one of these studies has reported a
sample size comparable to the dataset presented here. Second, Butler
and colleagues reported associations with source memory accuracy and
discriminability rather than recognition memory. Finally, the associa-
tion of BFCS volume and episodic memory seems to be specific for
subjects with impairment in the memory domain. For instance, Grothe
et al. (2016) suggested that BFCS atrophy effects on cognition are
mediated by disease-related cortical dysfunction.
4.1. Limitations
In our study, ‘g’ has been calculated from several cognitive tests
using principal component analysis. Thus, analysis of global cognitive
abilities and subtest performance is to some extent redundant. We
cannot exclude the possibility that our ‘g’ is biased towards measuring
cognitive subdomains, e.g. with over-representation of short term
memory (PAL, SSP, VRM free recall) and under-representation of long-
term memory. As a consequence, we also might overestimate the as-
sociation of volumes and ‘g’ by including tests of cognitive domains
which might have an unusual strong association with BFCS volume.
This is of particular relevance, since in the unadjusted models, the as-
sociation of BFCS volume with TMT-B performance was stronger than
the association with ‘g’, which nevertheless was confounded by age,
education and sex.
Segmentation of cholinergic cell groups in the basal forebrain
cannot be based on visual features of the cells in MR images (Teipel
et al., 2015; Wolf et al., 2014). Therefore, we have to assume that vo-
lumetric data of the BFCS have relatively more noise contamination
than brain volume which can be segmented by voxel intensity. Thus,
associations of cognition and brain volume are a priori stronger than
associations of cognition and BFCS volume due to noise distribution.
Finally, our results are to some extent inconclusive with respect to the
relative relevance of BFCS and total brain volume for cognition.
5. Conclusion
We were able to extend previous reports of BFCS volume association
with global cognitive performance in a large sample of older adults. Our
results suggest that contradictory findings of BFCS volume effects on
subtest performance reflect a specific association for low-performing
individuals, although these findings need further evidence.
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